LOTTE Biologics delivers flexible, scalable manufacturing solutions across the full product lifecycle, supporting programs from early development through commercial supply. Our capabilities span mammalian-cell-based drug substance production, high-titer and large-scale bioreactor operations, and fully integrated Bioconjugate manufacturing at our Syracuse campus. With a unified Dual Hub model, advanced technologies, and consistent global quality standards, we provide reliable, phase-appropriate execution to meet the diverse needs of our partners' therapeutic pipelines.
